Related Cardiometabolic Factors and Prevalence of Low HDL-cholesterol Levels and Atherogenic Dyslipidemia. SIMETAP-AD Study

Aim: To determine the crude and sex- and age-adjusted prevalence rates of atherogenic dyslipidemia (AD) and low HDL-cholesterol levels (low-HDLc), and to assess their associations with cardiovascular risk factors, chronic kidney disease, cardiovascular and cardiometabolic diseases. Methods: Population-based cross-sectional study conducted in Primary Care, with randomly selected adult subjects. The AD was considered if the patients had hypertriglyceridemia (triglycerides >= 150 mg/dL) and low.HDLc (< 40 mg/dL [men]; < 50 mg/dL [women]). Crude and sex- and age-adjusted prevalence rates were determined, and univariate and multivariate analysis were performed to assess related cardiometabolic factors. Results: Study population with 6,588 adults (55.9% women) with mean age 55.1 (+/- 17.5) years. The mean HDLc levels were 49.2 (+/- 12.6) mg/dL in men and 59.2 (+/- 14.7) mg/dL in women. The crude prevalence rates of tow-HDLc and AD were 30.8% (95%cI: 29.7-31.9), and 14.3% (95%CI: 13.5-15.2), respectively. The adjusted prevalence rates of low-HDLc were 28.0% in men and 31.0% in women, and AD were 16.4% in men and 10.6% in women. Seventy-three percent of the population with AD had high or very high cardiovascular risk. The independent factors associated with low HDLc or with AD were diabetes, smoking, abdominal obesity, and obesity. The major factors associated with low HDLc and AD were hypertriglyceridemia and diabetes, respectively. Conclusions: Almost a third of the adult population had low HDL-C and half of them met AD criteria. Cardiometabotic factors were associated with low HDL-C and AD, highlighting hypertriglyceridemia with low HDLc, and DM with AD. (C) 2020 Sociedad Espanola de Arteriosclerosis. Published by Elsevier Espana, S.L.U. All rights reserved.